,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,434064,6191,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,256,1,1,,434064,6191,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
2,330,1,1,,434064,6191,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
3,1159939,1,2,,312363988,6191,Unspecified,68068087.0,2859.0,,EC50,Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis,Confirmatory,,
4,1159940,1,2,,312363988,6191,Active,68068087.0,2859.0,,,Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution at 200 uM after 50 mins by resonant waveguide grating biosensor analysis in presence of GPR35 antagonist ML-145,Other,,
5,1159949,1,2,,312363988,6191,Inactive,68068087.0,2859.0,,,Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation up to 1 mM after 5 hrs by beta-lactamase reporter gene assay,Other,,
6,1159951,1,2,,312363988,6191,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis relative to control,Other,,
7,1159952,1,2,,312363988,6191,Inactive,68068087.0,2859.0,,,Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay relative to zaprinast,Other,,
8,1259407,1,1,,363901051,6191,Active,,,,,CCRIS mutagenicity studies,Other,,
